White House signs H.R. 7148 into law, tightening rules on PBMs distorting Missouri drug prices

Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
0Comments

The White House announced that congressional bill H.R. 7148 has been signed into law, which includes reforms targeting pharmacy benefit manager (PBM) practices by shifting compensation away from rebate-linked incentives and expanding transparency requirements, an issue gaining attention in Missouri. 

According to AJMC, the spending law introduces Medicare Part D PBM reforms designed to reduce incentives tied to higher list prices. The policy “delinks” PBM compensation from rebates and list prices by moving PBMs toward flat administrative fees, a change supporters say can weaken “rebate maximization” and steer plans away from higher-priced drugs that generate bigger rebates.

Under the new provisions described in coverage of the law, PBMs would be required to pass through 100% of rebates, fees, and other remuneration to the payer, with Centers for Medicare & Medicaid Services (CMS) monetary penalties available for noncompliance. The goal, as reported by AJMC, is to ensure rebate dollars do not remain with middlemen and to improve accountability for how savings are handled.

PBMs sit between insurers/payers, drug manufacturers, and pharmacies—negotiating rebates and building formularies and pharmacy networks that shape what patients pay and where they can fill prescriptions. Federal scrutiny has intensified: the FTC’s interim staff report on “prescription drug middlemen” argues PBM concentration and vertical integration can disadvantage patients and independent pharmacies without sufficient transparency.

Missouri’s Attorney General urged Congress to bar PBMs (and affiliates) from owning/operating pharmacies, warning that PBM vertical integration can “manipulate” drug prices and undermine fair competition. The state framed PBM ownership ties as enabling self-dealing that disadvantages independent pharmacies and can worsen affordability for patients.

The White House serves as the executive branch office supporting the President and communicates official administration actions through its public “Briefings & Statements” releases. These postings serve as the government’s on-the-record record for presidential actions and policy announcements, archived for public access on WhiteHouse.gov.



Related

Sara Brenner, Principal Deputy Commissioner at FDA

FDA carried out third most inspections of biologics companies in Missouri in 2025

In 2025, the U.S. Food and Drug Administration (FDA) carried out 26 inspections across 26 biologics companies in Missouri.

R. Matthew Price, United States Attorney for the Western District of Missouri

Randolph County man indicted for carjacking

A Moberly man faces federal charges after allegedly attempting carjacking at Jefferson City Memorial Airport. Authorities say he threatened a woman with weapons before being apprehended nearby. The case falls under Operation Take Back America.

R. Matthew Price, United States Attorney for the Western District of Missouri

Springfield man sentenced to five years for illegal machine gun possession

A Springfield man has been sentenced to five years in federal prison for possessing an illegal machine gun conversion device attached to his firearm. The case highlights ongoing efforts against violent crime through Operation Take Back America.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Show-Me State Times.